Rituximab (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Rituximab" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

4^th place

11^th place

1^st place

2^nd place

8^th place

low place

low place

communityoncology.net

Patel V, Mihatov N, Cooper N, Stasi R, Cunningham-Rundles S, Bussel JB,Long-term responses seen with rituximab in patients with ITP, Community Oncology Vol. 4 No. 2, February 2007:107 PDF Archiválva 2007. szeptember 29-i dátummal a Wayback Machine-ben

Feugier P. (2015). „A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas.” (angol nyelven). Future Oncol. 11 (9), 1327-42. o. DOI:10.2217/fon.15.57. PMID 25952779.

Shanafelt, Tait D, MD; Madueme, Hans L, MD; Wold, Robert C, PharmD; Tefferi, Ayalew, MD Rituximab for Immune Cytopenia in Adults: Idiopathic Thrombocytopenic Purpura, Autoimmune Hemolytic Anemia, and Evans Syndrome Mayo Clinic Proc. 2003;78:1340-1346 PDF Archiválva 2006. március 13-i dátummal a Wayback Machine-ben

Feugier P. (2015). „A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas.” (angol nyelven). Future Oncol. 11 (9), 1327-42. o. DOI:10.2217/fon.15.57. PMID 25952779.
Edwards J, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close D, Stevens R, Shaw T (2004). „Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.”. N Engl J Med 350 (25), 2572-81. o. PMID 15201414.
Binder M, Otto F, Mertelsmann R, Veelken H, Trepel M. (2006). „The epitope recognized by rituximab.”. Blood 108, 1975-1978. o. PMID 16705086.
Burton C, Kaczmarski R, Jan-Mohamed R (2003). „Interstitial pneumonitis related to rituximab therapy”. N Engl J Med 348 (26), 2690-1; discussion 2690-1. o. PMID 12826649.

McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 1998;16:2825-33. PMID 9704735.
Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura. Am J Hematol 2005;78:275-80. PMID 15795920.

Patel V, Mihatov N, Cooper N, Stasi R, Cunningham-Rundles S, Bussel JB,Long-term responses seen with rituximab in patients with ITP, Community Oncology Vol. 4 No. 2, February 2007:107 PDF Archiválva 2007. szeptember 29-i dátummal a Wayback Machine-ben
Shanafelt, Tait D, MD; Madueme, Hans L, MD; Wold, Robert C, PharmD; Tefferi, Ayalew, MD Rituximab for Immune Cytopenia in Adults: Idiopathic Thrombocytopenic Purpura, Autoimmune Hemolytic Anemia, and Evans Syndrome Mayo Clinic Proc. 2003;78:1340-1346 PDF Archiválva 2006. március 13-i dátummal a Wayback Machine-ben